December 29, 2018 : Issue #970

Our most popular articles  published in 2018:

Jan SGLT-2 Inhibitors Vs DPP-4 Inhibitors Vs. GLP1’s For Type 2 Diabetes
Feb Type 2 Diabetes Can Begin 20 Years Prior to Diagnosis
Mar American College of Physicians Recommending Controversial Increase in A1c of 7% to 8%
Apr Empagliflozin Reduces Cardiovascular Mortality
May Very Low Carbohydrate Diet Equals Better Diabetes Control 
Jun Prevent Diabetes With Intermittent Fasting?
Jul 37-Year-Old Hypertensive Drug Improves Beta Cell Function and Insulin Production
Aug Vitamin D Supplementation for Diabetes Prevention
Sep Nuts, Nuts, and More Nuts Lower A1c and Cardiovascular Disease
Oct WHO Guidelines Recommend Treatment Intensifications in Type 2 Diabetes  
Nov Possible Breakthrough In Treating Type 2 Diabetes and Prediabetes
Dec ADA’s Position on the Evaluation and Management of Type 2 Diabetes in Youth

Way back in 1985 TV funny man, David Letterman, shared his first Top 10 List (https://www.youtube.com/watch?v=gKjBNuGypnw) and over the next 30 years Dave shared a lot of lists with millions of viewers. These lists, as you know, were put together by his comedic writing teams, and really had nothing to do with his viewers’ likes and dislikes.

This week as we close out 2018, we decided to let you our readers pick the best articles of the year. Our Editorial staff has gone through the over 300 features to find which ones that you read the most each month of the year, and have complied them in one location.

Be sure to check out the article which was our most popular article for the whole year. I guarantee that you will be surprised by the choice (take our Test Your Knowledge quiz for the answer).

Have and safe and happy new year and we look forward to serving you in 2019 and beyond.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief

A new safety communication – Increased Risk of Ruptures or Tears in the Aorta Blood Vessel in Certain Patients, intended for: Health Professional, Infectious Disease, Cardiology, Patient was just added to the FDA MedWatch Webpage.  You can read the complete MedWatch Safety Alert that includes recommendations at: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm628960.htm

Can you guess which article published this year was the most popular of all?

How best to decide whether to use one or a combination of the new treatments and individualize the treatment for your patients.

Subtle elevations in fasting glucose and triglycerides associated with developing type 2 diabetes.

Organization says adults with type 2 diabetes can aim for an easier-to-achieve blood sugar target than what’s been used to guide treatment in the past.

Most important mediator due to changes in markers of plasma volume.

Low carbs equals lower blood sugars and control, with less hypoglycemia, but how low do our patients need to go?

In 2018, more people visited Diabetes in Control on their mobile devices than on a desktop (47% mobile, 44% desktop, 9% tablet)

It can improve insulin sensitivity, pancreatic response to blood sugars, and even prevent prediabetes from turning into diabetes.

Researchers discover safe and effective therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent onset type 1.

Vitamin D shows potential to lower HbA1c, FPG, insulin resistance, and 2-hour post-prandial glucose levels.

New study shows that nut intake may improve glycemic control and reduce risk of cardiovascular disease in people who have type 2 diabetes.

Medications suggested for second- and third-line treatments for diabetes management following treatment failure with metformin and sulfonylureas.

Diabetes in Control had nearly 2 million page views in 2018

Free potential treatment lowers blood sugars, helps with weight loss, drops blood pressure and cholesterol, and may add at least 10 years of quality of life.

Specific treatment recommendations outlined for this growing patient population.